ENDRA Life Sciences Inc. — All Filings
507 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
3/A
4
4/A
424B1
424B3
424B4
424B5
424B7
8-A12B
8-A12B/A
8-A12G
8-K
8-K/A
ARS
CERTNAS
CERTNYS
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-033878 | Mar 25, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-092253 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-092251 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-021415 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | 4 | 0001193125-26-021414 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | 4 | 0001193125-26-021413 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | 4 | 0001193125-26-021412 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | 4 | 0001193125-26-021411 | Jan 23, 2026 | Jan 21, 2026 |
| 8-K | CURRENT REPORT | 0001213900-25-121374 | Dec 15, 2025 | Dec 9, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-116103 | Nov 28, 2025 | — |
| SCHEDULE 13D | — | 0000898432-25-000936 | Nov 26, 2025 | — |
| 424B4 | PROSPECTUS | 0001213900-25-115097 | Nov 26, 2025 | — |
| SCHEDULE 13G/A | — | 0001079973-25-001775 | Nov 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-110897 | Nov 14, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-110887 | Nov 14, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0001079973-25-001729 | Nov 14, 2025 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-25-107232 | Nov 6, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-103810 | Oct 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-103707 | Oct 30, 2025 | Oct 29, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-103705 | Oct 30, 2025 | — |
| SCHEDULE 13G | — | 0001947975-25-000019 | Oct 28, 2025 | — |
| ARS | ARS | 0001654954-25-012257 | Oct 28, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA 14A | 0001654954-25-012256 | Oct 28, 2025 | — |
| DEF 14A | DEF 14A | 0001654954-25-012254 | Oct 28, 2025 | Dec 31, 2024 |
| D | — | 0001681682-25-000004 | Oct 24, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-012084 | Oct 23, 2025 | — |
| PRE 14A | PRE 14A | 0001654954-25-011931 | Oct 17, 2025 | Dec 31, 2024 |
| 4 | 4 | 0001193125-25-240662 | Oct 15, 2025 | Oct 10, 2025 |
| 8-K/A | FORM 8-K/A | 0001654954-25-011825 | Oct 15, 2025 | Oct 10, 2025 |
| 8-K | FORM 8-K | 0001654954-25-011797 | Oct 15, 2025 | Oct 10, 2025 |
| 10-Q | FORM 10-Q | 0001654954-25-009643 | Aug 14, 2025 | Jun 30, 2025 |
| S-1/A | FORM S-1/A | 0001654954-25-008477 | Jul 25, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-008318 | Jul 23, 2025 | — |
| S-1/A | FORM S-1/A | 0001654954-25-008117 | Jul 16, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-007893 | Jul 9, 2025 | — |
| S-1 | FORM S-1 | 0001654954-25-007870 | Jul 9, 2025 | — |
| 4 | 4 | 0000950170-25-091888 | Jul 1, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-091887 | Jul 1, 2025 | Jun 11, 2025 |
| 4 | 4 | 0000950170-25-091885 | Jul 1, 2025 | Jun 11, 2025 |
| 8-K | FORM 8-K | 0001654954-25-006811 | Jun 11, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-006282 | May 30, 2025 | May 27, 2025 |
| 10-Q | FORM 10-Q | 0001654954-25-005770 | May 15, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001654954-25-005768 | May 15, 2025 | — |
| DRS | — | 0001654954-25-005304 | May 9, 2025 | — |
| 10-K/A | FORM 10-K | 0001654954-25-003937 | Apr 7, 2025 | Dec 31, 2024 |
| S-8 | FORM S-8 | 0001654954-25-003848 | Apr 2, 2025 | — |
| 10-K | FORM 10-K | 0001654954-25-003612 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001654954-25-003611 | Mar 31, 2025 | — |
| SCHEDULE 13G/A | — | 0001079973-25-000276 | Feb 14, 2025 | — |
| 8-K | FORM 8-K | 0001654954-24-014793 | Nov 22, 2024 | — |